Medmen Clears HUGE DOJ Hurdle (Great News for US Weed Stocks) - Market Update - Sept/10/2019
Play • 30 min

The Medmen/Pharmacann acquisition passing DOJ regulatory hurdle is BIG news. Here's why:

- What is the DOJ 2nd Request Process?

- Why this is SO important to US Cannabis stocks?

- Which MSOs will benefit from this announcement?

- What this means going forward for US Weed Stocks?

- Are investors fully appreciating how important this is?

- How is the weed market performing since the August lows?

- Which weed stocks will benefit from this?

- Update on the Origin House trade



More episodes
Search
Clear search
Close search
Google apps
Main menu